These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
113 related articles for article (PubMed ID: 11475082)
1. [Primary diagnosis of papillary thyroid carcinoma in the framework of staging of malignant melanoma with F-18 deoxyglucose using PET]. Menzel C; Risse JH; Biersack HJ; Grünwald F Nuklearmedizin; 2001 Jun; 40(3):N23-4. PubMed ID: 11475082 [No Abstract] [Full Text] [Related]
2. Fortuitous detection of papillary carcinoma of the thyroid with F-18 FDG positron emission tomography in a patient with non-Hodgkin lymphoma. Kim CE; Joyce JM; Patel N; Lichter J Clin Nucl Med; 2003 Sep; 28(9):782-3. PubMed ID: 12973010 [TBL] [Abstract][Full Text] [Related]
3. Detecting metastatic neck lymph nodes in papillary thyroid carcinoma by 18F-2-deoxyglucose positron emission tomography and Tc-99m tetrofosmin single photon emission computed tomography. Wu YJ; Wu HS; Yen RF; Shen YY; Kao CH Anticancer Res; 2003; 23(3C):2973-6. PubMed ID: 12926147 [TBL] [Abstract][Full Text] [Related]
4. Detection of papillary thyroid cancer brain metastasis with FDG-PET/CT. Rini JN; Nguyen VT; Ben-Levi E; Naidich JJ; Yi Li J; Palestro CJ Clin Nucl Med; 2010 May; 35(5):357-9. PubMed ID: 20395715 [No Abstract] [Full Text] [Related]
5. Comparison of F-18 FDG to I-123 and I-131 scans in thyroid carcinoma. Bakheet SM; Powe JE; Hammami MM; Ahmed M Clin Nucl Med; 1997 Jun; 22(6):438-9. PubMed ID: 9193832 [No Abstract] [Full Text] [Related]
6. (18)F-FDG PET discovered an elusive cervical inflammatory pseudotumor associated with a papillary thyroid cancer. Modesto J; Gardeazabal I; Santos AM; Galofré JC Endocrinol Nutr; 2014; 61(6):338-40. PubMed ID: 24721020 [No Abstract] [Full Text] [Related]
9. Histological aggressiveness of fluorodeoxyglucose positron-emission tomogram (FDG-PET)-detected incidental thyroid carcinomas. Are C; Hsu JF; Ghossein RA; Schoder H; Shah JP; Shaha AR Ann Surg Oncol; 2007 Nov; 14(11):3210-5. PubMed ID: 17713821 [TBL] [Abstract][Full Text] [Related]
10. Determination of malignancy of thyroid nodules with positron emission tomography. Bloom AD; Adler LP; Shuck JM Surgery; 1993 Oct; 114(4):728-34; discussion 734-5. PubMed ID: 8211687 [TBL] [Abstract][Full Text] [Related]
11. Metastatic malignant melanoma to the thyroid gland detected by FDG-PET imaging. Basu S; Alavi A Clin Nucl Med; 2007 May; 32(5):388-9. PubMed ID: 17452870 [No Abstract] [Full Text] [Related]
12. Comparison of (18)F-FDG, (131)I-Na, and (201)Tl in diagnosis of recurrent or metastatic thyroid carcinoma. Shiga T; Tsukamoto E; Nakada K; Morita K; Kato T; Mabuchi M; Yoshinaga K; Katoh C; Kuge Y; Tamaki N J Nucl Med; 2001 Mar; 42(3):414-9. PubMed ID: 11337516 [TBL] [Abstract][Full Text] [Related]
13. Can [18F]-fluorodeoxyglucose standardized uptake values of PET imaging predict pathologic extrathyroid invasion of thyroid papillary microcarcinomas? Jeong HS; Chung M; Baek CH; Ko YH; Choi JY; Son YI Laryngoscope; 2006 Dec; 116(12):2133-7. PubMed ID: 17146385 [TBL] [Abstract][Full Text] [Related]
15. Focal uptake of (18)F-fluorodeoxyglucose by thyroid in patients with nonthyroidal head and neck cancers. Nam SY; Roh JL; Kim JS; Lee JH; Choi SH; Kim SY Clin Endocrinol (Oxf); 2007 Jul; 67(1):135-9. PubMed ID: 17465995 [TBL] [Abstract][Full Text] [Related]